QT Sense, a deep-tech biotech startup building tools to study living cells, announced it has secured €4 million in funding to accelerate its Quantum Nuova platform, a technology that lets scientists observe cellular processes in real time and reveal biochemical activity linked to disease. The funding includes a €3 million seed investment led by Cottonwood Technology Fund, with follow-on backing from existing investor QDNL Participations and an angel investor. In addition, the company received €600,000 from the ONCO-Q programme to support cancer research and €400,000 through the Quantum Forward Challenge for collaborative deployments with research partners. Most traditional lab methods…
This story continues at The Next Web Source